Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Mar 05 2025
Business
Mar 5 2025
3 min read

Press Release Mar 05 2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 05, 2025, titled "Zydus receives final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg".

View Attachment